Elevated concentrations of the serum or plasma YKL-40 were associated with OSA and other diseases, such as type 2 diabetes mellitus, atherosclerosis, endothelial dysfunction, and hypertension [16,17,18]. Here, CHI3L1 is linked to obstructive sleep apnea syndrome.